Krop Julie 4
4 · AMAG PHARMACEUTICALS, INC. · Filed Mar 4, 2020
Insider Transaction Report
Form 4
Krop Julie
SVP Clinical & Regulatory, CMO
Transactions
- Tax Payment
Common Stock
2020-03-02$7.75/sh−1,333$10,331→ 73,044 total
Footnotes (2)
- [F1]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 4,333 restricted stock units ("RSUs") on March 2, 2020.
- [F2]Reporting person's total beneficial ownership has been adjusted to reflect that no shares were awarded pursuant to the performance-based RSU award granted on February 23, 2017. The reporting person had previously reported beneficial ownership of 7,500 shares pursuant to the RSU award, which represented the target number of shares that could have been delivered based on the achievement of certain relative total stockholder return targets over a three year performance period, which were not met, and which target share amount was previously reported on a Form 4 filed on February 27, 2017.